Pharmacy Grand Rounds

Let's Hash it Out: Medical Marijuana in Chronic Pain Management

• ACPE Universal Activity Number (UAN): JA0000238-0000-20-028-L01-P
• Session Type: Knowledge-based
• CE Credits: A maximum of 0.75 contact hour (0.075 CEU) for the following: 
  • AAPA Category 1 CME Credits
  • ACPE
  • AMA PRA Category 1 Credits™
  • ANCC

• Session Fee: Free for Mayo Clinic staff

SESSION LOCATIONS

Live Session: (11:00am - 11:45am CST)
MN-RO-AL-MN-459-MAYO LH

Interactive Video Conference Room(s): 
MN-RO-GO-19-101 BARRETTE LH

Participants may attend by viewing: Live Webcast
Video Recording - access two weeks after session date

COURSE DESCRIPTION

As of January 2020, medical marijuana has been legalized for use in 33 states. State policies continue to change and we will presumably see this number continue to increase in the coming years. As more states legalize marijuana for both medicinal and recreational purposes, it is likely that we will encounter more patients utilizing this substance for numerous reasons. One of the indications more commonly cited as a reason for its use is various types of pain. This presentation aims to review literature on use of medical marijuana for pain treatment and additional factors to take into consideration when caring for patients using medical marijuana.

At the conclusion of this knowledge-based CE session, participants should be able to:

1. Describe mechanisms of action of medical marijuana in pain relief
2. Review evidence of medical marijuana use in chronic pain management
3. Discuss medication management considerations for patients using medical marijuana

Session Announcement

FACULTY INFORMATION

Allison P. Golbach, PharmD
PGY1 Pharmacy Resident
Mayo Clinic Hospital - Rochester, MN

Allison received a Doctor of Pharmacy degree from Drake University, in Des Moines, IA.  She is a current PGY1 Pharmacy Resident at Mayo Clinic Hospital-Rochester with practice interests in hematology, oncology, and pharmacogenomics.

DISCLOSURE STATEMENTS

As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program:

The faculty report the following relationships:

• Allison P. Golbach, PharmD
  • Declares no financial relationships pertinent to this session
  • Declares off-label use of devices and medications will be discussed during this presentation, including:
    • Dronabinol
    • Nabilone

Course Director and Planning Committee Members declare no relevant financial relationship(s) pertinent to this session.  Members include:

• Brenda Amaris
• Mary Ellen Cordes, MS, APRN, CNC, NE-BC
• Michael Huckabee, MPAS, PA-C, PhD
• Wayne (Nick) Nicholson, MD, PharmD, BCPS
• Garrett Schramm, PharmD, BCPS
• Lee Skrupky, PharmD, BCPS